Get started
Keyword

controlled attenuation parameter

Description: An ultrasound-based measurement obtained by transient elastography that estimates liver fat by assessing attenuation of the signal.
OpenAlex ID: keywords/controlled-attenuation-parameter
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2019 · Peter J. Eddowes, Magali Sasso, et al. · Gastroenterology · 1,416
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
2016 · Thomas Karlas, David Petroff, et al. · Journal of Hepatology · 1,268
Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
2010 · Magali Sasso, Michel Beaugrand, et al. · Ultrasound in Medicine & Biology · 862
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
2015 · Kento Imajo, Takaomi Kessoku, et al. · Gastroenterology · 812
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
2020 · Philip N Newsome, Magali Sasso, et al. · ˜The œLancet. Gastroenterology & hepatology · 805
PDF
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
2016 · Charlie C. Park, Phirum Nguyen, et al. · Gastroenterology · 711
PDF
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
2018 · Mohammad S. Siddiqui, Raj Vuppalanchi, et al. · Clinical Gastroenterology and Hepatology · 615
Ultrasound-based techniques for the diagnosis of liver steatosis
2019 · Giovanna Ferraioli, Livia Beatriz Soares Monteiro · World Journal of Gastroenterology · 507
PDF
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
2015 · Raymond Kwok, Kai Chow Choi, et al. · Gut · 480
Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease
2018 · Masanori Shimizu, Kunihiro Suzuki, et al. · Diabetes Obesity and Metabolism · 392
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations
2014 · Victor de Lédinghen, Julien Vergniol, et al. · Journal of Hepatology · 379
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
2017 · Cyrielle Caussy, Mosab H. Alquiraish, et al. · Hepatology · 375
PDF
Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter ( CAP ) and transient elastography
2012 · Victor de Lédinghen, Julien Vergniol, et al. · Liver International · 367
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
2020 · Romina Lomonaco, Eddison Godinez Leiva, et al. · Diabetes Care · 352
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
2012 · Robert P. Myers, Aaron Pollett, et al. · Liver International · 343
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
2022 · Veeral Ajmera, Sandra Cepin, et al. · Journal of Hepatology · 321
PDF
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®
2011 · M. Sasso, V. Miette, et al. · Clinics and Research in Hepatology and Gastroenterology · 284
Noninvasive evaluation of NAFLD
2013 · Laurent Castera, Valérie Vilgrain, et al. · Nature Reviews Gastroenterology & Hepatology · 273
Transient elastography (FibroScan ® ) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
2016 · Ivana Mikolasevic, Lidija Orlic, et al. · World Journal of Gastroenterology · 272
PDF
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
2021 · David Petroff, Valentin Blank, et al. · ˜The œLancet. Gastroenterology & hepatology · 268
Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease
2017 · Raj Vuppalanchi, Mohammad S. Siddiqui, et al. · Hepatology · 261
PDF
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
2024 · Huapeng Lin, Hye Won Lee, et al. · JAMA · 246
PDF
Association between SII and hepatic steatosis and liver fibrosis: A population-based study
2022 · Ruijie Xie, Mengde Xiao, et al. · Frontiers in Immunology · 215
PDF
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values
2016 · Salvatore Petta, Vincent Wai‐Sun Wong, et al. · Hepatology · 214
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C
2011 · M. Sasso, I. Tengher‐Barna, et al. · Journal of Viral Hepatitis · 214
Works count: 2,768
Citation count: 41,720
Year
Topic
Type